Boehringer has just started recruiting in its Phase 2A study on Diabetic Retinopathy (2nd indication), bringing on one site in the US. Like the NASH trial, we should hear of the coming weeks that the 1st patient has been dosed which will trigger the €10 million milestone payment to PXS. Happy days
https://clinicaltrials.gov/ct2/show/NCT03238963?term=BI1467335&rank=2
Ann: Boehringer Initiating Phase 2a Study Diabetic Retinopathy, page-22
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
